Led by Prof @Jamie_Rossjohn FRS we are focused on understanding molecular bases underpinning protective and aberrant immunity

Monash University, Australia
Joined July 2014
NHMRC Investigator Grants out today. A devastating day for many. I have already received messages from some of the best researchers I know who have missed out. The senior levels had a cutoff of 5.93 (females), 6.2 (males) - according to my sources. The impact will be wide spread. The damage being done at the moment to the sector is totally unacceptable. We need to do a lot more to support our research community.
8
21
2
74
5,854
#StarsOfScience – Professor Jane Visvader's groundbreaking discoveries at @WEHI_research have fundamentally changed how we understand breast development and cancer.
1
5
12
1,015
Early bird registration pricing for CD1-MR1 2025 ends this Friday, 6th June! Get on it 👉👉 cd1mr1.com
2
2
320
Congrats to Hien, 1st author of this study that arose from her hard work during her PhD.
Latest research from @jbiolchem “The molecular basis of T cell receptor recognition of citrullinated tenascin-C presented by HLA-DR4” by Dao et al. jbc.org/article/S0021-9258(2… @ASBMB @Jamie_Rossjohn
1
10
513
In collaboration with Moody lab, latest paper from @RossjohnLab describing the structure of a lipopeptide bound to a MHC-I like molecule found in chickens - hopefully this study will not ruffle too many feathers.
1
1
9
516
Your immune system gradually loses it top team players when we get older 👱➡️👵 Our study in @eBioMedicine investigates how long our good immune cells stay around – a 🧵⬇️ go.unimelb.edu.au/4sep @CvandeSandt @KatherineKedz @TheDohertyInst #Influenza #AgingResearch
1
5
2
19
902
Our latest paper demonstrating the potential of “our” DOT cells against colorectal cancer has just been published in @NatureCancer: rdcu.be/ehYwG Many congrats to the whole team, especially @RafaelBlancoDom! :)
5
15
1
79
3,010
Researchers in Science #Immunology have identified CD8+ T cells from human donors that can recognize naturally occurring influenza variants spanning more than 100 years, including the 1918 influenza A and 2024 #H5N1. @Jamie_Rossjohn @kedzierskalab scim.ag/4hpSzh1
2
51
3
159
11,283
🚨 Flu breakthrough! 🚨 Researchers at @TheDohertyInst & @MonashUni have discovered immune cells that recognise flu viruses even as they mutate—a further step toward a universal flu vaccine. go.unimelb.edu.au/d7z8 @UniMelbMDHS @TheRMH @oanheei @Jamie_Rossjohn @kedzierskalab @KatherineKedz
1
12
21
1,508
Rossjohn lab retweeted
TCR-peptide-HLA ternary structures define molecular mechanisms of TCR cross-reactivity toward natural influenza variants @SciImmunology science.org/doi/10.1126/scii… @RossjohnLab @Jamie_Rossjohn @kedzierskalab @KatherineKedz
7
2
26
1,841
Ziggy enjoying park time #roughcollie
1
6
326
Researchers paid $8.968 billion for their findings to be freely accessible. 🧵1/10
82
592
163
2,083
498,681
Fast and accurate modeling of TCR-peptide-MHC complexes using tFold-TCR 1. tFold-TCR introduces a high-throughput, end-to-end method for predicting TCR-peptide-MHC (TCR-pMHC) complex structures, overcoming challenges in TCR-pMHC interactions and enabling rapid and precise 3D structure modeling. 2. The model leverages a specially trained protein language model (PLM) that extracts intra- and inter-chain residue contact information, eliminating the need for laborious multiple sequence alignment (MSA) searches and achieving remarkable speed improvements. 3. Compared to existing methods like AlphaFold-3, tFold-TCR shows a 30.7% increase in prediction accuracy, achieving fast and reliable results in seconds, significantly enhancing computational efficiency. 4. The tFold-TCR model was used to construct TCRStructDB, the largest database of TCR-pMHC structures, including 2.2 million TCRs, 0.8 million pMHCs, and 45,000 TCR-pMHC complexes, providing unprecedented insights into immune system interactions. 5. With the ability to predict unliganded TCRs, unbound pMHCs, and complex TCR-pMHC structures, tFold-TCR advances our understanding of the immune system, supporting cancer immunotherapy and improving vaccine development. 6. Despite superior performance on TCRs and MHC-I interactions, the model's prediction of MHC-II complexes lags behind AlphaFold-3, indicating challenges due to the structural complexities of MHC-II molecules. 7. The platform allows large-scale structural predictions, offering a robust tool for drug discovery, vaccine design, and personalized immunotherapies, and is available via the online TCRStructDB database. 8. tFold-TCR sets a new standard in modeling TCR-pMHC complexes, providing a critical resource for advancing immunological research and therapeutic strategies. @Jamie_Rossjohn @RossjohnLab @supercs08 @aaguaijie 💻Code: github.com/TencentAI4S/tfold 📜Paper: biorxiv.org/content/10.1101/… #Immunotherapy #TCRModeling #CancerResearch #Bioinformatics #MachineLearning
1
11
60
3,799
Rossjohn lab retweeted
@Immutep in collab with @RossjohnLab first to publish structure of LAG-3/HLA-II complex & resolve how human LAG-3 binds to its main ligand, providing better foundation for development of blocking #LAG3 therapeutics incl its own small molecule program. bit.ly/3DkXnp2
5
16
544
Tokyo qualified! 💥 Isobel Batt-Doyle storms home in 2:22:59 at the Valencia Marathon, finishing 8th overall in the women's field. Izzi also met the qualifying standard for the Tokyo World Athletics Championships next September after skyrocketing to third on the Australian all-time list. #AthleticsNation
9
110
2,907
💥 Blazing Buchanan 💥 Andy Buchanan has rewritten the history books, becoming the first ever Aussie to break the 2:07 barrier in the marathon. 🏃‍♂️🔥 Clocking a phenomenal 2:06:26, Andy shattered Brett Robinson's record from 2022 finishing 16th overall, with his historic run also qualifying him for the World Athletics Championships next September. More to come. #AthleticsNation
2
16
3
164
4,740